The evaluation of pathological grade of glioma with comprehensive MRI technique.

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-11001472

Enrollment

Unknown

Registered

2011-08-08

Start date

2011-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: glioma patients proved pathologically, MRI data (conventional MRI, MRS, DWI/DTI and ESWAN) are available in glioma patients.

Exclusion criteria

Exclusion criteria: Non-glioma patients, glioma patients that MRI data ( conventional MRI, MRS, DWI/DTI and ESWAN ) are not available

Design outcomes

Primary

Measure	Time frame
FA;CBF;Enhancement ratio;CBV;NAA/Cho;MTT;ADC;NAA/C;	—

Countries

China

Contacts

Public ContactDong Zhang

hszhangd@163.com+86 13008308976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026